Annual FCF
-$101.86 M
-$3.61 M-3.68%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual free cash flow is -$101.86 million, with the most recent change of -$3.61 million (-3.68%) on December 31, 2022.
- During the last 3 years, EVLO annual FCF has fallen by -$26.84 million (-35.79%).
- EVLO annual FCF is now -650.94% below its all-time high of -$13.56 million, reached on December 31, 2016.
Performance
EVLO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$10.46 M
+$9.37 M+47.27%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly free cash flow is -$10.46 million, with the most recent change of +$9.37 million (+47.27%) on September 30, 2023.
- Over the past year, EVLO quarterly FCF has increased by +$12.14 million (+53.73%).
- EVLO quarterly FCF is now -131.92% below its all-time high of -$4.51 million, reached on March 31, 2017.
Performance
EVLO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$73.99 M
+$12.14 M+14.10%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM free cash flow is -$73.99 million, with the most recent change of +$12.14 million (+14.10%) on September 30, 2023.
- Over the past year, EVLO TTM FCF has increased by +$31.85 million (+30.10%).
- EVLO TTM FCF is now -1541.26% below its all-time high of -$4.51 million, reached on March 31, 2017.
Performance
EVLO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
EVLO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.7% | +53.7% | +30.1% |
| 3 y3 years | -35.8% | +43.4% | +0.7% |
| 5 y5 years | -307.3% | +26.5% | +1.4% |
EVLO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.7% | at low | at high | +64.0% | at high | +33.5% |
| 5 y | 5-year | -36.9% | at low | at high | +64.0% | at high | +33.5% |
| alltime | all time | -650.9% | at low | -131.9% | +64.0% | -1541.3% | +33.5% |
Evelo Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$10.46 M(-47.3%) | -$73.99 M(-14.1%) |
| Jun 2023 | - | -$19.83 M(-2.3%) | -$86.13 M(-7.4%) |
| Mar 2023 | - | -$20.29 M(-13.4%) | -$93.06 M(-8.6%) |
| Dec 2022 | -$101.86 M(+3.7%) | -$23.42 M(+3.6%) | -$101.86 M(-3.8%) |
| Sep 2022 | - | -$22.60 M(-15.6%) | -$105.84 M(-4.8%) |
| Jun 2022 | - | -$26.76 M(-8.0%) | -$111.22 M(+10.4%) |
| Mar 2022 | - | -$29.09 M(+6.1%) | -$100.73 M(+2.5%) |
| Dec 2021 | -$98.24 M(+32.1%) | -$27.40 M(-2.1%) | -$98.24 M(+8.9%) |
| Sep 2021 | - | -$27.98 M(+72.0%) | -$90.20 M(+11.8%) |
| Jun 2021 | - | -$16.27 M(-38.8%) | -$80.70 M(-0.4%) |
| Mar 2021 | - | -$26.59 M(+37.4%) | -$81.03 M(+8.9%) |
| Dec 2020 | -$74.38 M | -$19.36 M(+4.8%) | -$74.38 M(-0.1%) |
| Sep 2020 | - | -$18.48 M(+11.4%) | -$74.48 M(-2.9%) |
| Jun 2020 | - | -$16.59 M(-16.8%) | -$76.72 M(+0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$19.95 M(+2.5%) | -$76.09 M(+1.4%) |
| Dec 2019 | -$75.01 M(+42.2%) | -$19.46 M(-6.1%) | -$75.01 M(+3.8%) |
| Sep 2019 | - | -$20.73 M(+29.9%) | -$72.25 M(+9.9%) |
| Jun 2019 | - | -$15.96 M(-15.4%) | -$65.74 M(+5.5%) |
| Mar 2019 | - | -$18.87 M(+13.0%) | -$62.29 M(+18.1%) |
| Dec 2018 | -$52.74 M(+110.9%) | -$16.69 M(+17.3%) | -$52.74 M(+20.1%) |
| Sep 2018 | - | -$14.22 M(+13.7%) | -$43.90 M(+22.0%) |
| Jun 2018 | - | -$12.51 M(+34.3%) | -$35.97 M(+20.6%) |
| Mar 2018 | - | -$9.32 M(+18.7%) | -$29.82 M(+19.2%) |
| Dec 2017 | -$25.01 M(+84.4%) | -$7.85 M(+24.6%) | -$25.01 M(+45.7%) |
| Sep 2017 | - | -$6.30 M(-0.9%) | -$17.16 M(+58.0%) |
| Jun 2017 | - | -$6.36 M(+41.0%) | -$10.86 M(+141.0%) |
| Mar 2017 | - | -$4.51 M | -$4.51 M |
| Dec 2016 | -$13.56 M | - | - |
FAQ
- What is Evelo Biosciences annual free cash flow?
- What is the all time high annual FCF for Evelo Biosciences?
- What is Evelo Biosciences annual FCF year-on-year change?
- What is Evelo Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Evelo Biosciences?
- What is Evelo Biosciences quarterly FCF year-on-year change?
- What is Evelo Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Evelo Biosciences?
- What is Evelo Biosciences TTM FCF year-on-year change?
What is Evelo Biosciences annual free cash flow?
The current annual FCF of EVLO is -$101.86 M
What is the all time high annual FCF for Evelo Biosciences?
Evelo Biosciences all-time high annual free cash flow is -$13.56 M
What is Evelo Biosciences annual FCF year-on-year change?
Over the past year, EVLO annual free cash flow has changed by -$3.61 M (-3.68%)
What is Evelo Biosciences quarterly free cash flow?
The current quarterly FCF of EVLO is -$10.46 M
What is the all time high quarterly FCF for Evelo Biosciences?
Evelo Biosciences all-time high quarterly free cash flow is -$4.51 M
What is Evelo Biosciences quarterly FCF year-on-year change?
Over the past year, EVLO quarterly free cash flow has changed by +$12.14 M (+53.73%)
What is Evelo Biosciences TTM free cash flow?
The current TTM FCF of EVLO is -$73.99 M
What is the all time high TTM FCF for Evelo Biosciences?
Evelo Biosciences all-time high TTM free cash flow is -$4.51 M
What is Evelo Biosciences TTM FCF year-on-year change?
Over the past year, EVLO TTM free cash flow has changed by +$31.85 M (+30.10%)